rfhg_170011.1

Basic information about the TSS

---

TSS ID: rfhg_170011.1 Species: human Chr: chr14		Start: 99481174 End: 99481190 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D2758585,EH38E1741450)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000557165.5:-5 GeneID: 8812 HGNC/MGI_ID: HGNC:1596 UniProt_ID: Nearer transcript ids and distances: ENST00000389879.9:219 NM_001099402.2:219 ENST00000553636.1:222 ENST00000557441.5:222 BC015935:233 ENST00000555049.5:234 AK311075:234 ENST00000555842.1:235 ENST00000556641.5:260 view more...

Gene_name: CCNK Gene_symbol: CCNK Gene_synonyms: CPR4 Gene_source: HGNC:1596

TATA-Box annotation

---

Distance to TSS:	-227
Nearest PromoterID:	NM_001099402
Entrez ID:	8812
Nearest Unigene:	Hs.510409
Nearest Refseq:	NM_003858
Nearest Ensembl:	ENSG00000090061
Gene Name:	CCNK
Gene Alias:	CPR4|IDDHDF
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.470588
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CCNK p2@CCNK p3@CCNK p5@CCNK
Sample		p1@CCNK	p2@CCNK	p3@CCNK	p5@CCNK
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	58.83	2.34	0.58	0.97
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	69.60	0.61	1.01	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	72.15	1.74	2.12	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	56.34	1.25	1.46	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	62.54	1.12	0.90	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	61.05	1.74	1.16	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	92.38	3.05	3.05	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	74.85	1.21	1.45	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	71.60	1.50	0.85	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	69.56	2.90	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	48.10	1.21	0.40	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	66.27	2.03	1.63	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	27.40	0.81	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	36.84	0.75	0.75	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	28.98	0.44	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	28.17	1.01	0.75	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	32.98	0.00	0.66	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	25.31	0.00	0.00	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	30.39	0.53	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	26.33	1.05	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	28.07	0.94	0.67	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	36.77	0.52	0.69	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	34.12	0.52	0.26	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	31.55	0.73	0.49	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	26.31	1.29	0.52	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	27.22	0.32	0.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	35.71	0.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	38.19	1.65	1.41	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	22.94	0.97	0.48	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	31.31	1.09	0.54	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	24.70	0.63	0.84	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	24.81	0.98	1.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	23.21	1.27	0.42	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	39.26	0.49	0.66	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	25.80	1.12	0.37	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	26.25	0.19	0.57	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	31.07	0.61	0.20	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	28.41	0.81	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	35.38	0.54	0.27	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	25.93	0.24	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	25.17	0.94	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	30.89	0.73	0.29	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	24.67	0.63	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	30.42	0.87	0.52	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	34.33	0.20	0.80	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	28.62	0.93	0.23	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	18.71	1.20	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	25.93	0.89	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	27.29	0.72	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	32.35	1.01	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	40.58	1.43	0.00	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	40.92	2.00	1.33	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	307.83	27.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	29.45	1.77	1.06	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	33.80	0.00	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	193.79	4.19	3.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	90.47	1.38	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	35.00	1.94	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	30.19	1.93	1.93	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	73.87	0.31	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	38.07	0.71	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	27.48	2.80	0.56	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	156.04	3.18	0.80	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	52.66	2.38	1.02	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	26.97	3.90	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	26.62	1.42	1.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	355.61	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	331.69	0.00	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	29.74	0.98	2.44	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	36.69	0.99	0.00	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	35.65	0.00	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	47.69	0.66	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	34.65	1.55	0.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	31.19	1.22	0.61	0.00
Adipocyte - breast, donor1	11376-118A8	40.23	0.48	0.32	0.00
Adipocyte - breast, donor2	11327-117E4	38.02	1.60	0.96	0.16
Adipocyte - omental, donor1	11473-119C6	59.67	0.64	0.38	0.38
Adipocyte - omental, donor2	11474-119C7	28.40	0.75	2.24	0.75
Adipocyte - omental, donor3	11475-119C8	28.80	0.67	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	42.11	1.28	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	17.59	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	45.61	0.00	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	31.63	0.17	1.04	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	52.80	1.37	0.20	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	37.83	0.77	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	41.54	0.00	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	37.62	0.59	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	57.59	0.48	0.24	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	40.67	0.65	0.32	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	32.52	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	37.28	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	22.87	0.42	0.83	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	32.65	0.25	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	26.51	0.33	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	21.01	0.30	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	82.21	0.66	0.66	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	52.35	1.43	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	33.54	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	87.43	0.36	0.90	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	45.18	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	58.96	1.03	0.82	0.41
Anulus Pulposus Cell, donor1	11248-116E6	48.52	0.80	1.37	0.34
Anulus Pulposus Cell, donor2	11463-119B5	27.92	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	45.83	0.45	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	52.53	0.87	2.17	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	25.68	2.14	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	54.10	1.20	1.20	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	48.06	0.00	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	27.72	0.00	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	43.53	0.32	0.65	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	43.20	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	32.66	0.00	1.19	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	54.61	1.13	1.13	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	39.91	0.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	22.57	2.51	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	38.05	0.49	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	38.21	1.36	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	26.09	0.45	0.15	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	58.94	0.00	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	35.33	1.13	1.32	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	40.89	0.27	1.07	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	41.94	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	35.66	0.83	0.50	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	18.01	0.00	2.40	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	53.10	3.54	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	40.48	1.37	0.34	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	25.17	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	39.80	0.97	0.97	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	38.70	0.38	0.38	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	20.59	1.21	1.21	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	39.90	0.57	1.14	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	35.91	0.43	1.07	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	27.10	0.77	0.26	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	38.01	0.47	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	37.94	0.96	0.96	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	22.83	0.71	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	41.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	42.75	0.30	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	23.76	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	55.94	0.51	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	37.18	0.51	0.51	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	20.33	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	44.88	0.86	0.86	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	32.81	0.21	0.85	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	27.84	0.00	1.45	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	48.18	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	34.24	0.51	1.02	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	27.80	0.00	4.63	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	52.81	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	36.24	0.21	0.43	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	24.67	0.00	1.80	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	43.74	1.46	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	34.25	0.46	0.92	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	33.15	2.55	10.20	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	29.24	0.25	0.76	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	47.27	1.24	0.41	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	30.60	0.92	0.61	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	58.80	0.96	1.43	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	39.69	0.22	1.77	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	24.41	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	44.31	0.00	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	38.66	0.26	0.79	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	30.89	0.36	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	81.55	1.11	0.25	0.25
Astrocyte - cerebellum, donor2	11580-120F5	53.57	0.68	0.86	0.17
Astrocyte - cerebellum, donor3	11661-122F5	54.11	0.63	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	57.52	0.00	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	55.97	0.81	0.81	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	53.85	0.30	0.60	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	210.56	4.13	0.92	3.10
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	214.23	4.76	2.13	2.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	212.69	4.10	0.23	1.71
Basophils, donor1	12241-129G9	196.67	0.26	0.00	0.26
Basophils, donor2	12242-129H1	225.50	0.72	1.08	0.36
Basophils, donor3	12243-129H2	103.49	0.73	0.00	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	62.96	0.65	0.65	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	58.98	0.46	0.46	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	0.00	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	37.03	0.00	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	64.05	0.42	0.42	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	100.64	0.92	1.15	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	43.55	1.44	0.90	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	95.64	1.03	0.41	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	107.60	0.70	0.70	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	56.60	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	93.08	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	134.69	0.00	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	176.14	4.64	0.56	1.11
CD14+ Monocytes, donor3	11381-118B4	138.75	2.20	0.44	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	59.72	0.85	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	61.41	0.76	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	58.19	0.33	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	99.88	1.73	0.87	1.16
CD14+ monocytes - mock treated, donor2	11873-125C1	105.31	1.51	1.21	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	110.39	1.42	1.42	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	108.47	3.01	0.67	1.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	97.16	1.10	0.55	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	141.32	1.24	1.49	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	116.11	1.96	0.59	1.17
CD14+ monocytes - treated with BCG, donor2	11870-125B7	106.65	2.31	0.71	0.89
CD14+ monocytes - treated with BCG, donor3	11880-125C8	146.68	0.87	0.65	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	115.42	1.64	0.00	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	166.86	0.53	0.53	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	191.92	2.22	2.22	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	107.69	2.53	0.74	0.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	109.95	2.00	0.80	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	103.27	0.83	0.83	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	110.27	1.60	0.92	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	134.82	1.36	0.23	0.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	126.14	2.18	0.44	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	108.13	2.15	1.08	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	122.47	3.31	0.52	1.57
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	111.94	2.10	0.84	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	133.56	3.31	1.47	2.20
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	106.38	3.17	1.06	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	165.40	1.32	0.88	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	108.11	3.14	0.70	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	107.04	4.83	0.37	1.49
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	151.10	0.65	1.29	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	131.45	2.46	0.00	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	143.25	1.16	0.23	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	155.67	0.46	1.39	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	82.61	0.65	1.09	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	89.39	0.23	0.46	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	63.69	0.22	1.52	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	108.69	0.78	0.62	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	97.98	1.57	0.70	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	213.16	1.34	0.67	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	64.81	0.77	1.02	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	91.34	0.22	0.44	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	76.64	0.00	0.63	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	52.84	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	54.92	0.00	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	44.53	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	53.84	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	86.84	0.54	1.07	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	61.07	0.00	0.70	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	53.34	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	63.28	0.00	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	133.15	2.47	0.82	2.47
CD19+ B Cells, donor2	11624-122B4	135.65	2.90	1.45	0.00
CD19+ B Cells, donor3	11705-123B4	161.04	0.50	3.03	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	239.20	2.83	2.02	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	124.64	2.00	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	69.28	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	137.08	0.56	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	48.47	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	71.48	0.00	0.45	0.00
CD4+ T Cells, donor1	11225-116C1	279.93	2.14	1.07	0.00
CD4+ T Cells, donor2	11306-117C1	222.29	5.51	4.90	1.84
CD4+ T Cells, donor3	11382-118B5	191.84	2.13	0.00	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	111.54	1.02	0.26	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	101.29	0.22	0.22	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	99.17	0.29	0.29	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	135.12	1.42	0.47	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	127.82	0.70	1.40	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	98.89	0.00	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	106.36	0.72	1.30	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	84.39	1.19	0.85	0.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	73.51	0.48	0.48	0.81
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	106.25	0.45	1.34	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	104.82	0.00	1.05	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	174.67	0.88	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	143.36	2.11	1.69	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	80.82	1.04	2.70	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	59.14	0.67	0.67	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	171.05	1.09	1.09	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	162.39	0.00	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	161.39	1.79	3.59	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	119.42	0.56	0.74	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	79.72	0.87	1.08	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	90.79	0.63	0.63	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	120.84	0.51	3.03	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	114.81	0.00	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	203.09	1.31	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	95.51	0.49	1.98	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	66.47	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	51.65	1.40	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	126.28	0.55	0.55	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	156.80	0.49	0.25	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	103.18	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	97.41	0.36	1.43	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	99.72	0.00	4.15	1.38
CD8+ T Cells, donor1	11226-116C2	239.98	0.65	1.64	0.65
CD8+ T Cells, donor2	11307-117C2	234.27	1.13	3.75	2.63
CD8+ T Cells, donor3	11383-118B6	238.85	1.77	2.52	1.51
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	54.60	0.92	0.23	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	56.56	0.96	0.72	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	59.92	2.19	1.92	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	83.76	0.30	2.10	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	57.12	1.68	1.20	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	61.85	1.14	0.23	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	64.97	0.87	1.52	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	69.22	1.05	1.58	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	59.80	1.64	0.94	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	73.36	2.42	2.11	1.51
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	65.94	1.74	1.45	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	63.14	0.27	0.53	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	64.35	0.00	0.88	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	65.13	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	61.91	2.98	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	63.75	2.16	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	58.12	2.01	0.86	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	58.69	1.41	1.41	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	90.00	1.58	1.90	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	57.51	2.46	0.92	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	77.26	0.64	1.60	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	66.93	1.91	1.91	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	63.45	0.39	1.18	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	55.97	0.76	0.76	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	105.19	1.61	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	97.92	0.00	0.70	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	129.23	4.01	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	16.45	3.66	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	31.13	0.49	1.48	0.99
Cardiac Myocyte, donor3	11686-122I3	32.41	0.53	0.11	0.11
Chondrocyte - de diff, donor1	11261-116G1	69.68	1.73	0.69	0.69
Chondrocyte - de diff, donor2	11338-117F6	40.51	0.71	1.07	0.36
Chondrocyte - de diff, donor3	11410-118E6	36.52	1.14	1.02	0.34
Chondrocyte - re diff, donor2	11339-117F7	217.55	4.48	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	60.26	0.81	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	57.95	0.23	0.80	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	48.10	1.71	1.07	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	42.83	0.62	0.44	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	116.00	0.83	1.10	0.64
Corneal Epithelial Cells, donor1	11526-119I5	86.29	0.66	0.66	0.00
Corneal Epithelial Cells, donor2	11606-120I4	71.67	2.28	3.41	0.00
Corneal Epithelial Cells, donor3	11687-122I4	67.23	0.26	1.02	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	49.03	0.50	0.00	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	49.20	0.95	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	37.96	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	46.98	0.43	0.65	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	119.57	0.00	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	109.68	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	117.11	0.48	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	100.73	0.33	0.33	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	52.81	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	68.72	0.85	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	51.51	0.00	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	52.07	0.29	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	80.23	0.71	0.71	1.18
Endothelial Cells - Artery, donor3	11413-118E9	88.53	0.70	0.88	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	50.32	0.00	0.22	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	55.99	0.30	0.91	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	63.99	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	49.92	0.30	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	46.34	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	35.73	0.85	0.14	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	85.23	0.00	0.40	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	53.46	1.57	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	113.44	0.99	0.62	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	46.06	1.09	0.43	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	55.57	0.85	0.12	0.61
Endothelial Cells - Vein, donor1	11267-116G7	48.91	0.00	2.28	0.00
Endothelial Cells - Vein, donor2	11344-117G3	76.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	45.22	1.10	0.31	0.16
Eosinophils, donor1	12244-129H3	121.98	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	514.88	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	513.62	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	66.21	0.24	0.24	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	47.84	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	50.08	0.41	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	23.10	2.08	0.88	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	40.41	2.93	3.47	0.98
Fibroblast - Aortic Adventitial, donor1	11245-116E3	73.86	0.73	0.97	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	67.83	0.41	0.27	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	63.07	1.69	0.74	0.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	64.03	0.53	0.79	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	71.09	1.66	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	45.36	0.45	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	80.34	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	45.11	0.47	1.10	0.47
Fibroblast - Cardiac, donor4	11452-119A3	74.87	0.30	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	52.41	0.13	0.63	0.51
Fibroblast - Cardiac, donor6	11460-119B2	48.06	0.15	0.15	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	92.99	0.40	0.54	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	36.67	0.43	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	45.41	0.00	1.46	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	155.22	0.69	0.92	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	56.14	0.51	0.68	0.85
Fibroblast - Dermal, donor1	11269-116G9	38.74	0.70	0.47	0.23
Fibroblast - Dermal, donor2	11346-117G5	80.19	0.47	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	42.31	0.85	1.33	0.00
Fibroblast - Dermal, donor4	11450-119A1	57.09	0.45	0.23	0.00
Fibroblast - Dermal, donor5	11454-119A5	70.83	0.70	0.17	0.35
Fibroblast - Dermal, donor6	11458-119A9	76.66	0.81	0.49	0.49
Fibroblast - Gingival, donor1	11237-116D4	90.37	0.42	0.21	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	76.24	1.83	0.00	0.52
Fibroblast - Gingival, donor2	11318-117D4	70.90	1.05	2.37	0.53
Fibroblast - Gingival, donor3	11394-118C8	86.53	0.87	0.39	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	66.49	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	30.31	0.88	0.18	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	83.87	1.25	0.94	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	78.57	0.81	0.68	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	127.39	3.88	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	70.78	1.32	0.15	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	88.63	0.68	1.09	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	82.82	1.43	0.44	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	59.72	1.61	0.44	0.00
Fibroblast - Lung, donor1	11270-116H1	47.58	0.00	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	77.59	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	47.91	1.48	1.27	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	414.84	0.83	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	88.11	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	61.01	1.12	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	295.55	0.81	0.81	0.81
Fibroblast - Mammary, donor2	11620-122A9	103.85	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	107.21	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	72.93	0.78	0.97	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	103.45	1.97	0.91	0.91
Fibroblast - Periodontal Ligament, donor3	11395-118C9	145.65	0.31	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	46.94	0.00	0.76	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	50.22	0.54	1.08	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	35.26	0.46	0.12	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	45.10	0.44	1.33	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	200.14	0.61	0.41	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	90.88	0.67	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	31.23	0.79	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	98.03	1.98	0.20	1.19
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	44.23	0.36	1.07	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	61.88	0.79	0.39	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	61.07	0.90	0.60	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	101.26	0.97	0.76	0.54
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	79.97	1.52	0.76	0.51
Fibroblast - skin normal, donor1	11553-120C5	60.71	0.00	0.66	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	97.25	1.00	0.20	0.80
Fibroblast - skin normal, donor2	11561-120D4	104.38	0.70	0.70	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	115.15	1.81	2.72	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	70.58	0.50	1.08	0.50
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	90.26	0.68	0.34	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	73.57	0.33	0.33	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	87.77	0.64	0.43	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	84.00	1.18	0.84	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	72.14	0.63	2.04	0.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	886.39	22.16	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	45.32	0.87	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	47.67	0.35	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	74.17	0.52	0.26	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	54.94	0.26	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	63.54	1.53	0.77	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	80.40	3.19	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	93.85	2.00	2.57	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	70.04	1.65	1.38	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	54.11	1.60	1.14	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	57.66	0.79	1.59	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	59.48	2.38	1.59	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	55.12	1.30	0.98	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	77.39	2.21	1.33	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	97.51	1.84	1.27	1.13
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	108.24	1.23	0.74	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	84.08	2.15	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	92.67	2.48	0.37	1.24
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	95.10	1.66	1.11	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	81.52	1.42	1.22	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	60.47	1.14	0.23	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	89.56	2.24	0.87	1.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	73.88	1.09	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	54.66	1.18	0.30	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	94.10	1.11	0.64	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	52.73	0.67	0.89	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	68.96	0.60	1.01	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	91.44	0.51	1.02	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	108.80	1.15	0.62	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	140.89	1.25	0.21	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	131.50	1.54	0.17	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	72.81	1.33	0.55	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	75.54	0.58	0.42	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	77.18	0.82	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	60.65	1.86	0.62	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	74.83	1.27	0.92	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	54.53	1.17	0.50	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	50.04	0.66	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	75.52	1.48	0.74	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	55.44	0.65	1.62	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	66.07	0.96	0.64	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	58.18	1.23	0.28	0.57
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	50.62	0.16	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	57.47	0.91	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	62.93	1.25	0.42	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	47.42	0.22	0.88	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	42.64	0.56	0.84	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	55.37	1.02	0.37	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	52.95	1.34	0.53	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	48.96	1.68	0.77	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	48.96	1.81	0.39	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	47.44	0.54	0.27	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	51.25	0.92	0.74	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	42.77	0.66	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	148.76	4.96	0.99	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	62.39	1.06	1.32	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	48.22	0.61	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	319.99	5.08	0.00	1.78
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	111.47	0.60	1.39	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	106.62	2.31	1.23	1.08
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	132.98	3.48	0.82	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	56.33	0.31	0.94	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	42.38	0.28	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	85.78	3.69	1.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	44.55	2.47	2.47	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	88.19	0.77	1.55	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	46.53	3.21	0.00	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	50.43	1.74	3.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	65.42	1.30	1.63	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	79.07	1.65	2.06	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	69.98	0.00	3.33	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	59.56	1.40	1.12	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	68.96	0.98	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	67.11	1.68	2.52	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	77.61	1.91	1.91	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	75.74	0.34	2.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	68.91	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	83.61	0.57	2.86	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	62.16	0.89	2.96	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	60.99	1.69	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	82.01	2.90	0.83	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	71.11	2.30	1.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	42.15	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	56.89	0.00	1.15	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	46.29	0.65	2.93	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	30.10	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	73.97	1.16	1.93	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	105.10	2.74	0.68	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	67.09	2.48	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	51.90	1.89	0.94	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	68.80	3.62	1.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	61.04	1.02	1.53	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	66.61	2.79	2.39	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	76.47	0.99	0.99	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	94.44	3.54	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	61.85	0.00	4.08	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	86.90	3.07	3.95	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	62.73	3.39	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	40.59	1.79	2.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	50.47	1.94	3.40	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	74.18	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	55.72	1.25	1.66	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	78.71	1.12	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	45.99	1.59	2.22	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	34.67	0.00	1.25	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	48.74	1.51	0.70	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	52.16	0.84	1.01	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	55.28	1.14	0.68	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	51.16	0.66	0.22	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	46.64	0.43	0.86	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	48.87	0.86	0.86	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	49.07	0.87	0.75	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	48.89	0.86	1.03	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	42.29	0.00	0.96	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	69.39	1.68	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	95.65	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	44.94	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	86.06	0.35	1.41	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	51.58	0.00	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	45.11	1.22	1.40	0.35
Hepatocyte, donor1	11523-119I2	35.11	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	32.32	1.08	1.08	0.00
Hepatocyte, donor3	11684-122I1	33.74	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	80.93	0.65	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	161.85	1.75	0.35	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	45.00	0.27	0.41	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	25.47	0.00	3.18	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	46.73	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	13.84	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	30.03	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	35.88	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	69.85	1.62	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	38.35	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	39.94	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	34.41	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	42.13	1.11	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	54.17	0.63	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	21.65	0.00	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	48.45	0.00	0.00	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	20.93	1.61	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	54.60	0.00	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	37.36	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	36.17	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	43.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	41.07	0.00	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	44.44	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	50.58	0.00	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	35.57	0.00	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	45.28	1.28	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	23.69	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	45.70	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	46.46	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	45.37	0.31	0.93	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	36.88	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	22.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	43.11	0.00	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	42.05	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	32.42	0.00	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	34.88	0.00	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	45.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	24.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	59.74	3.20	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	36.02	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	17.10	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	52.46	2.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	48.41	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	37.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	41.24	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	111.63	1.39	0.49	0.24
Keratinocyte - epidermal, donor2	11349-117G8	66.76	1.17	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	63.51	1.51	1.42	0.76
Keratinocyte - oral, donor1	11251-116E9	154.27	2.16	3.41	0.57
Keratocytes, donor1	11527-119I6	175.35	1.38	0.69	1.72
Keratocytes, donor2	11607-120I5	94.92	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	56.32	0.40	0.59	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	26.37	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	36.68	0.00	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	47.86	0.23	0.69	0.46
Lens Epithelial Cells, donor3	11690-122I7	47.43	0.50	0.61	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	49.68	0.24	0.83	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	30.98	0.28	1.67	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	38.25	0.63	0.47	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	28.50	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	32.46	0.00	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	37.30	0.75	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	39.40	0.82	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	32.87	0.51	0.51	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	35.75	0.70	0.84	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	41.53	0.40	1.58	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	29.86	0.00	0.78	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	25.37	0.74	0.93	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	32.40	0.70	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	34.59	0.72	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	32.83	0.55	0.55	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	40.03	0.00	1.54	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	28.37	0.31	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	45.75	0.55	0.18	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	32.58	0.00	0.66	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	33.09	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	40.08	1.24	1.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	36.37	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	29.89	0.54	0.81	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	36.18	0.30	0.15	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	42.51	1.04	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	30.57	0.21	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	33.23	0.90	1.50	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	28.89	2.06	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	34.81	0.19	0.38	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	32.34	0.21	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	34.41	0.48	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	36.06	0.99	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	33.08	0.74	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	44.43	1.11	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	26.68	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	29.70	0.96	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	43.42	0.64	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	31.35	0.61	0.61	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	35.97	0.42	0.84	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	27.02	1.07	0.36	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	27.63	0.48	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	31.12	0.93	0.62	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	30.44	0.00	0.36	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	31.36	0.65	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	26.84	0.47	1.41	0.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	55.69	0.50	1.61	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	22.28	0.77	1.02	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	34.61	0.30	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	74.78	0.00	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	114.30	1.53	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	86.84	0.74	0.00	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	134.98	3.39	1.69	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	101.28	1.41	2.11	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	86.86	0.93	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	107.69	2.58	6.18	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	96.35	1.19	2.38	5.95
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	87.76	1.13	0.68	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	100.92	1.74	2.91	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	101.74	3.15	2.25	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	155.40	1.63	1.35	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	104.76	2.05	7.19	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	91.04	1.06	2.82	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	73.29	0.67	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	119.71	1.02	5.09	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	105.92	2.13	3.74	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	113.93	2.65	2.65	1.13
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	117.19	0.61	3.68	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	132.10	0.00	1.63	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	109.12	2.92	3.33	1.46
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	119.11	2.24	4.76	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	108.19	1.03	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	114.96	2.90	6.68	1.74
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	95.36	1.20	2.99	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	91.29	0.55	2.21	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	145.99	2.83	4.60	2.83
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	119.48	1.84	3.69	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	99.01	1.15	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	133.55	1.54	2.69	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	139.83	5.66	7.36	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	109.12	3.28	0.82	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	137.37	1.81	6.78	2.71
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	122.80	5.03	5.03	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	99.34	0.75	2.99	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	136.37	4.09	4.46	1.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	96.06	1.72	3.02	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	89.91	3.43	3.43	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	130.27	4.00	4.66	2.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	113.42	3.02	3.62	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	70.39	0.00	4.27	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	107.24	4.47	3.09	1.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	112.18	1.61	6.44	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	82.82	0.67	2.69	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	125.20	4.07	5.19	1.48
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	105.83	2.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	68.75	3.17	3.17	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	118.44	1.20	4.40	2.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	114.85	1.45	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	108.08	0.77	1.53	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	133.68	2.96	8.88	2.47
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	95.03	2.82	4.70	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	113.64	1.51	2.01	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	116.71	3.15	4.51	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	132.52	3.44	8.61	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	123.36	2.23	9.35	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	138.81	2.74	3.91	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	130.63	3.96	4.62	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	113.64	4.15	5.71	3.11
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	171.96	6.13	5.69	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	113.50	1.68	2.80	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	107.32	1.77	2.21	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	131.14	2.70	2.31	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	125.07	2.53	3.54	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	92.76	1.44	3.84	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	124.43	5.57	5.17	3.58
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	117.27	3.04	1.82	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	91.30	0.69	2.08	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	126.54	2.28	3.80	1.90
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	149.24	4.65	4.65	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	115.49	2.42	1.81	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	128.98	3.49	6.34	1.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	149.26	3.73	2.67	2.13
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	116.66	2.30	2.87	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	131.64	2.06	6.69	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	176.13	4.24	3.54	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	157.19	1.70	4.54	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	156.84	4.16	4.58	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	182.45	3.13	4.70	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	134.45	1.67	3.76	2.09
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	138.93	3.72	6.50	2.32
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	117.75	2.68	2.68	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	121.36	1.60	0.53	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	157.19	4.45	7.68	2.83
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	100.95	1.84	8.26	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	126.25	3.56	2.67	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	131.07	2.85	2.28	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	114.27	4.60	4.60	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	118.74	1.09	1.09	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	115.82	1.78	4.45	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	147.91	1.82	2.60	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	116.04	1.33	3.98	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	130.95	2.08	2.08	2.08
Macrophage - monocyte derived, donor1	11232-116C8	47.86	0.23	0.23	0.23
Macrophage - monocyte derived, donor2	11313-117C8	42.76	0.55	0.18	0.18
Macrophage - monocyte derived, donor3	11389-118C3	47.84	1.05	0.79	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	23.36	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	108.54	1.90	1.58	0.48
Mallassez-derived cells, donor3	11930-125I4	102.99	0.69	1.11	0.56
Mammary Epithelial Cell, donor1	11273-116H4	106.72	1.89	1.79	0.40
Mammary Epithelial Cell, donor2	11350-117G9	100.76	1.74	1.45	0.58
Mammary Epithelial Cell, donor3	11422-118F9	54.87	0.25	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	2113.81	40.68	1.36	16.27
Mast cell, donor1	11563-120D6	89.65	0.65	0.32	0.97
Mast cell, donor2	11565-120D8	106.09	1.19	0.00	0.00
Mast cell, donor3	11566-120D9	128.10	0.90	0.00	1.13
Mast cell, donor4	11567-120E1	105.49	0.89	0.18	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	112.67	0.67	0.55	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	98.06	1.17	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	57.36	0.57	0.92	0.11
Mast cell, expanded, donor8	11941-126A6	78.83	1.34	1.00	0.33
Melanocyte - dark, donor1	11502-119F8	31.94	0.20	0.30	0.10
Melanocyte - dark, donor2	11582-120F7	32.53	0.69	1.04	0.69
Melanocyte - dark, donor3	11663-122F7	66.28	0.65	1.38	0.29
Melanocyte - light, donor1	11274-116H5	57.83	0.94	0.71	0.24
Melanocyte - light, donor2	11351-117H1	42.31	2.05	0.68	0.00
Melanocyte - light, donor3	11423-118G1	22.55	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	51.54	0.62	0.83	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	37.65	0.54	0.54	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	67.23	0.27	0.00	0.27
Meningeal Cells, donor1	11493-119E8	183.98	0.87	0.00	0.12
Meningeal Cells, donor2	11573-120E7	77.91	0.00	0.44	0.00
Meningeal Cells, donor3	11654-122E7	106.03	1.55	0.98	0.73
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	46.20	0.00	0.57	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	57.96	0.30	0.10	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	52.57	1.31	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	64.10	0.00	3.92	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	39.47	0.72	2.15	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	48.92	0.64	0.64	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	49.26	1.01	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	107.24	1.54	1.76	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	106.67	0.00	1.46	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	76.11	0.41	0.82	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	50.14	0.69	1.25	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	46.84	0.00	0.74	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	59.21	0.66	1.05	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	47.48	0.30	0.89	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	37.37	4.67	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	88.38	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	51.39	0.35	1.42	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	37.84	0.31	0.63	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	31.20	0.73	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	45.88	0.80	0.80	0.53
Mesothelial Cells, donor2	12156-128G5	34.53	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	45.02	0.87	0.72	0.51
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	9.45	1.35	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	48.02	0.49	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	37.10	0.59	0.59	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	32.54	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	37.13	0.62	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	11.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	43.05	0.50	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	33.98	0.93	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	29.87	0.20	0.81	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	33.66	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	33.63	0.88	0.88	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	36.47	1.52	0.00	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	11.84	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	48.60	0.21	0.21	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	15.65	1.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	34.57	0.60	0.30	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	46.67	0.25	0.75	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	38.50	0.95	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	16.03	0.55	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	48.58	0.46	0.69	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	42.49	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	36.89	0.82	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	39.05	0.43	0.64	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	36.01	0.89	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	44.90	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	26.87	0.00	0.51	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	13.26	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	41.58	0.27	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	33.53	0.88	0.29	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	8.72	4.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	37.48	1.44	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	46.43	1.60	1.20	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	19.20	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	52.06	0.00	1.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	45.11	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	12.14	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	16.01	1.28	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	55.29	0.50	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	16.70	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	8.84	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	51.97	1.03	0.68	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	24.94	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	16.33	2.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	46.85	0.28	0.28	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	29.09	1.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	15.73	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	38.31	0.60	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	59.27	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	34.17	2.77	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	52.36	1.71	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	47.53	0.14	0.14	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	43.02	0.52	0.52	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	54.05	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	20.33	1.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	36.03	1.07	0.27	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	60.46	0.60	0.60	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	36.73	0.42	0.14	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	41.73	0.96	0.32	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	67.00	0.44	0.66	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	28.82	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	49.15	0.85	0.85	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	63.17	0.25	0.49	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	10.43	1.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	50.28	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	49.59	0.29	0.29	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	60.59	0.41	0.41	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	40.50	0.60	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	14.26	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	46.00	0.99	2.30	1.64
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	29.45	0.00	2.10	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	33.21	0.00	1.19	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	20.49	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	42.81	0.75	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	25.84	0.27	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	36.08	0.34	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	30.94	2.95	2.95	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	35.18	0.73	1.47	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	37.33	7.78	3.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	55.58	0.00	1.60	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	50.23	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	39.39	1.01	5.05	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	44.27	0.84	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	58.56	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	31.15	0.00	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	37.25	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	34.74	0.00	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	165.59	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	117.45	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	66.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	100.39	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	59.24	1.08	0.43	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	48.08	2.09	0.52	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	27.37	0.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	17.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	70.54	0.95	0.38	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	25.53	3.19	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	10.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	141.50	0.00	1.84	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	16.32	0.00	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	30.22	0.93	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	21.35	0.54	0.27	1.35
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	35.74	0.42	0.42	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	256.10	11.13	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	30.77	0.99	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	30.04	0.27	0.54	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	19.27	0.45	0.45	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	22.37	0.65	0.33	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	34.99	0.55	1.09	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	21.22	0.00	1.06	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	22.81	0.60	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	89.26	1.97	1.64	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	20.33	0.49	0.65	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	50.97	0.53	0.71	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	20.39	0.70	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	14.71	0.92	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	18.00	0.32	0.96	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	82.77	1.38	1.38	2.07
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	214.92	2.53	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	28.96	1.11	0.00	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	21.17	0.85	0.85	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	27.30	0.47	0.24	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	13.31	0.00	0.00	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	803.47	9.03	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	25.32	0.67	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	19.84	0.45	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	15.08	0.40	0.79	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	13.00	0.93	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	32.16	0.76	1.14	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	22.81	0.98	2.28	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	14.82	0.44	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	35.28	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	22.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	25.26	2.66	0.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	25.79	0.50	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	21.06	0.77	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	28.43	0.00	0.60	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	41.11	0.44	0.66	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	18.97	0.68	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	137.96	0.00	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	19.51	0.00	0.61	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	17.94	0.31	0.63	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	17.86	1.21	0.61	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	22.15	1.58	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	85.02	1.13	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	111.27	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	50.69	0.62	0.87	0.00
Myoblast, donor2	11322-117D8	49.48	0.19	1.34	0.58
Myoblast, donor3	11398-118D3	41.54	0.34	0.00	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	78.51	3.21	0.73	0.58
Natural Killer Cells, donor1	11230-116C6	234.02	2.77	1.23	0.31
Natural Killer Cells, donor2	11311-117C6	204.46	3.62	2.71	0.30
Natural Killer Cells, donor3	11387-118C1	182.95	2.39	0.55	0.74
Neural stem cells, donor1	11275-116H6	174.57	4.36	0.00	0.36
Neural stem cells, donor2	11352-117H2	200.27	3.85	0.00	0.00
Neurons, donor1	11494-119E9	70.55	4.55	1.14	1.14
Neurons, donor2	11574-120E8	49.32	0.88	0.00	0.00
Neurons, donor3	11655-122E8	62.48	1.64	1.64	0.82
Neutrophils, donor1	11233-116C9	459.36	8.35	3.71	7.42
Neutrophils, donor2	11314-117C9	327.57	11.60	5.80	5.80
Neutrophils, donor3	11390-118C4	499.06	7.94	1.22	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	75.99	0.59	2.14	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	18.56	0.33	0.33	1.30
Nucleus Pulposus Cell, donor3	11462-119B4	29.88	0.40	0.20	0.20
Olfactory epithelial cells, donor1	11933-125I7	35.24	1.24	1.10	0.41
Olfactory epithelial cells, donor2	11934-125I8	54.86	1.59	1.88	1.59
Olfactory epithelial cells, donor3	11935-125I9	41.20	0.91	0.45	0.68
Olfactory epithelial cells, donor4	11936-126A1	42.08	1.27	1.07	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	69.81	0.00	0.60	0.60
Osteoblast - differentiated, donor1	11276-116H7	80.82	1.28	0.00	0.43
Osteoblast - differentiated, donor2	11353-117H3	38.87	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	19.24	1.86	0.62	0.00
Osteoblast, donor1	11277-116H8	92.83	0.20	0.59	0.39
Osteoblast, donor2	11354-117H4	115.88	2.81	0.70	1.40
Osteoblast, donor3	11426-118G4	68.60	0.89	0.71	0.00
Pancreatic stromal cells, donor1	11249-116E7	96.53	1.18	1.18	0.76
Pericytes, donor1	11491-119E6	62.09	0.78	0.67	0.11
Pericytes, donor2	11571-120E5	41.65	0.45	0.23	0.00
Pericytes, donor3	11652-122E5	64.90	1.02	0.81	1.02
Perineurial Cells, donor1	11499-119F5	53.23	0.11	1.02	0.11
Perineurial Cells, donor2	11579-120F4	53.27	0.28	0.28	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	214.19	0.32	0.32	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	136.88	2.94	0.98	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	144.04	1.29	0.78	0.65
Placental Epithelial Cells, donor1	11278-116H9	55.49	0.24	0.96	0.24
Placental Epithelial Cells, donor2	11355-117H5	60.99	1.11	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	45.55	0.20	1.37	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	28.16	1.27	0.32	0.95
Preadipocyte - breast, donor1	11467-119B9	46.15	0.94	0.75	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	57.17	0.65	0.65	0.13
Preadipocyte - breast, donor2	11328-117E5	48.63	0.90	0.45	0.23
Preadipocyte - omental, donor1	11468-119C1	56.05	0.43	0.32	0.43
Preadipocyte - omental, donor2	11329-117E6	59.80	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	59.02	1.58	0.86	1.15
Preadipocyte - perirenal, donor1	11469-119C2	46.26	0.98	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	110.26	1.23	0.61	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	105.72	1.95	1.59	1.42
Preadipocyte - subcutaneous, donor3	11428-118G6	62.32	1.02	0.68	0.85
Preadipocyte - visceral, donor1	11280-116I2	97.43	1.40	0.47	0.93
Preadipocyte - visceral, donor2	11357-117H7	95.26	4.14	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	57.57	1.04	0.63	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	95.04	1.36	1.66	0.75
Prostate Epithelial Cells, donor2	11331-117E8	56.87	2.03	0.95	1.08
Prostate Epithelial Cells, donor3	11404-118D9	69.50	2.51	0.80	0.92
Prostate Stromal Cells, donor1	11254-116F3	83.60	0.91	1.71	0.46
Prostate Stromal Cells, donor2	11332-117E9	79.43	2.15	2.33	0.36
Prostate Stromal Cells, donor3	11405-118E1	52.24	0.83	1.15	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	68.98	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	56.97	0.42	0.83	0.28
Renal Epithelial Cells, donor1	11517-119H5	65.43	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	59.75	1.42	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	64.79	0.95	1.59	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	43.57	0.68	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	57.81	0.81	1.08	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	49.95	1.78	1.33	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	53.24	0.00	0.00	1.33
Renal Mesangial Cells, donor1	11518-119H6	76.59	1.54	1.98	0.00
Renal Mesangial Cells, donor2	11598-120H5	61.44	0.00	1.25	0.00
Renal Mesangial Cells, donor3	11679-122H5	44.66	0.55	0.55	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	79.45	0.81	0.27	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	53.55	0.00	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	60.36	0.00	0.19	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	52.12	0.26	1.04	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	56.28	1.14	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	43.22	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	51.94	0.75	1.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	64.55	0.94	0.27	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	41.99	3.57	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	133.19	3.85	3.85	3.30
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	121.81	4.64	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	69.17	1.43	0.00	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	49.45	1.19	0.70	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	63.69	0.78	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	94.27	1.86	1.86	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	63.17	1.40	0.47	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	81.59	1.62	1.62	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	54.08	0.82	0.55	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	63.53	1.21	0.76	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	47.84	0.54	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	56.95	0.86	0.72	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	54.09	0.97	0.32	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	56.65	0.44	1.33	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	46.07	1.15	0.38	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	53.94	0.75	0.56	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	98.84	2.25	0.56	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	46.45	1.46	0.27	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	66.58	0.78	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	66.26	1.53	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	50.41	0.75	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	43.73	1.12	1.68	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	61.69	1.20	0.34	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	38.84	0.18	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	55.80	1.47	0.74	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	61.12	0.81	0.40	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	62.03	1.65	0.94	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	66.67	0.79	0.40	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	65.48	1.17	0.23	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	48.31	1.24	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	66.58	1.77	1.33	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	51.80	0.21	1.04	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	59.08	1.08	0.81	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	45.30	1.02	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	61.89	1.35	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	72.21	1.72	0.86	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	49.93	0.55	0.27	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	68.95	2.79	0.82	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	47.89	1.02	0.51	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	76.05	0.74	0.44	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	56.78	0.53	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	46.73	1.52	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	42.62	0.95	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	73.36	0.81	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	45.67	0.57	0.19	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	57.64	2.10	0.70	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	47.45	0.30	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	47.49	1.59	0.12	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	91.99	0.87	0.29	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	49.28	1.22	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	41.89	0.60	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	52.93	1.81	0.45	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	60.81	2.70	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	66.48	2.60	0.47	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	45.46	3.63	0.43	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	51.68	1.80	0.60	0.00
Schwann Cells, donor1	11498-119F4	54.54	0.56	0.56	0.00
Schwann Cells, donor2	11578-120F3	44.23	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	39.22	0.66	0.44	0.22
Sebocyte, donor1	11220-116B5	365.91	1.10	0.55	0.55
Sebocyte, donor2	11301-117B5	120.40	5.97	0.92	4.14
Sebocyte, donor3	11378-118B1	102.23	2.47	0.62	0.82
Sertoli Cells, donor1	11255-116F4	64.61	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	56.49	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	80.24	1.06	0.97	0.35
Skeletal Muscle Cells, donor2	11358-117H8	33.25	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	63.54	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	42.10	0.63	0.31	0.00
Skeletal Muscle Cells, donor5	11455-119A6	46.23	0.59	0.74	0.30
Skeletal Muscle Cells, donor6	11459-119B1	59.41	0.62	0.62	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	84.17	0.38	1.01	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	60.50	1.00	1.28	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	66.07	0.60	0.79	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	102.45	0.76	1.01	0.67
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	56.45	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	44.17	0.55	1.10	0.14
Skin - palm, donor1	10286-104F7	51.04	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	41.23	1.01	1.01	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	260.91	4.91	1.64	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	53.36	2.60	1.04	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	103.42	0.56	0.56	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	68.08	1.27	1.13	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	173.60	0.42	0.42	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	87.02	1.50	1.27	0.45
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	58.94	0.93	2.47	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	70.03	1.78	0.44	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	77.59	0.00	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	93.70	1.10	1.10	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	90.18	0.39	0.79	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	70.30	0.77	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	40.03	1.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	73.19	0.53	0.27	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	70.71	1.77	0.89	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	14.34	0.38	0.00	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	35.49	0.00	0.98	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	42.82	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	38.58	0.28	0.57	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	88.17	0.00	0.49	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	35.62	1.22	0.61	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	81.58	1.01	0.00	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	67.33	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	51.02	2.38	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	48.08	0.29	0.59	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	62.63	0.86	1.29	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	57.31	0.63	0.73	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	104.25	0.31	0.46	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	52.82	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	47.52	0.60	0.90	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	80.57	1.02	2.05	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	66.20	0.63	1.02	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	88.06	2.72	0.40	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	83.74	1.59	0.91	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	65.21	0.00	1.21	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	86.90	1.59	1.85	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	71.51	0.93	1.07	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	74.00	2.13	0.38	1.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	23.34	1.01	0.00	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	89.11	0.75	0.45	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	52.51	1.50	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	90.46	1.29	3.88	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	72.55	0.47	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	76.24	2.02	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	63.93	0.31	1.57	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	56.34	0.29	1.18	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	73.14	0.00	0.33	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	38.31	1.40	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	94.99	0.72	0.29	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	75.21	1.27	0.76	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	50.39	0.00	0.94	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	86.78	0.42	1.82	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	48.68	0.34	0.17	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	55.24	0.95	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	99.58	0.24	1.22	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	70.70	0.88	0.66	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	20.48	0.29	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	41.20	1.17	0.58	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	62.41	2.38	1.59	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	85.18	2.98	0.74	1.86
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	60.37	0.72	1.80	1.80
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	49.11	1.42	0.85	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	69.71	1.18	0.39	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	52.82	1.78	0.25	1.52
Smooth muscle cells - airway, control, donor2	11967-126D5	29.95	0.80	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	28.42	2.51	1.25	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	30.25	0.46	0.00	0.00
Synoviocyte, donor1	11291-117A4	63.12	0.50	0.67	0.17
Synoviocyte, donor2	11368-117I9	45.93	0.84	0.84	0.34
Synoviocyte, donor3	11440-118H9	33.96	2.68	0.45	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	132.21	0.36	1.07	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	124.87	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	79.88	1.16	0.00	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	109.82	0.36	0.50	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	48.71	0.00	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	60.13	0.00	1.72	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	68.40	0.62	0.12	0.12
Urethra, donor2	10319-105A4	39.57	7.19	0.00	0.00
Urothelial Cells, donor1	11520-119H8	96.70	0.53	0.27	0.53
Urothelial Cells, donor2	11600-120H7	61.69	0.40	0.40	0.00
Urothelial Cells, donor3	11681-122H7	57.53	0.69	0.69	0.46
Urothelial cells, donor0	11216-116B1	101.42	1.34	3.12	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	162.83	0.00	0.89	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	147.25	1.43	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	104.05	0.68	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	119.83	0.00	0.34	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	110.40	0.58	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	132.24	0.00	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	124.82	0.92	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	75.77	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	72.41	2.34	0.99	0.12
Wilms' tumor cell line:HFWT	10597-108E3	22.88	1.76	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	66.76	1.40	0.28	0.00
achilles tendon, donor2	10292-104G4	53.73	10.33	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	104.02	2.29	0.76	1.78
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	140.70	1.39	0.70	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	145.89	1.42	0.71	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	169.80	4.08	0.27	1.63
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	143.91	3.94	1.97	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	63.44	0.21	0.63	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	110.25	1.36	0.27	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	99.14	1.76	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	109.44	2.04	0.41	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	86.98	1.16	0.78	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	135.24	1.84	1.10	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	46.81	3.90	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	128.74	1.86	0.70	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	146.28	2.85	2.59	2.07
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	104.04	2.34	1.46	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	93.88	2.32	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	95.00	1.23	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	25.17	1.53	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	125.45	0.85	1.28	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	130.11	1.21	0.30	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	156.46	0.48	0.00	1.44
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	93.77	1.34	1.11	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	98.40	0.67	1.33	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	78.04	1.86	1.86	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	152.17	2.64	1.13	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	107.29	1.31	1.31	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	44.99	5.62	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	55.81	0.24	0.47	0.47
adipose tissue, adult, pool1	10010-101C1	68.72	0.93	0.47	0.16
adipose, donor1	10184-103D4	177.10	1.76	4.69	1.17
adipose, donor2	10185-103D5	36.90	1.22	0.41	0.00
adipose, donor3	10186-103D6	47.65	1.09	0.27	0.27
adipose, donor4	10187-103D7	74.54	0.87	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	121.05	1.42	1.42	0.32
adrenal gland, adult, pool1	10081-102A9	25.46	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	116.06	0.93	0.53	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	62.53	1.07	0.00	0.71
amniotic membrane cells, donor1	12235-129G3	37.79	1.16	0.70	0.23
amniotic membrane cells, donor2	12236-129G4	31.11	0.00	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	44.78	0.88	0.29	0.59
amygdala - adult, donor10196	10167-103B5	58.10	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	73.60	1.42	0.00	0.81
amygdala, newborn, donor10223	10360-105E9	43.90	1.61	0.65	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	108.61	1.78	0.64	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	63.32	1.32	0.66	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	85.18	0.33	0.67	0.33
aorta, adult, pool1	10052-101G7	48.44	0.39	0.78	0.98
appendix, adult	10189-103D9	56.28	1.16	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	38.86	0.69	1.38	0.00
artery, adult	10190-103E1	36.68	2.72	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	66.20	0.87	0.14	0.14
b cell line:RPMI1788	10427-106D4	124.46	1.19	1.78	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	57.99	0.83	1.11	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	134.96	0.79	0.99	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	73.81	0.50	1.17	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	48.65	1.68	0.56	0.56
bladder, adult, pool1	10011-101C2	66.81	1.30	0.11	0.33
blood, adult, pool1	10053-101G8	50.94	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	40.25	0.00	0.00	0.00
bone marrow, adult	10192-103E3	95.83	6.07	4.05	0.67
brain, adult, donor1	10084-102B3	31.78	1.03	0.00	0.00
brain, adult, pool1	10012-101C3	54.45	1.45	0.67	0.45
brain, fetal, pool1	10085-102B4	45.41	8.01	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	68.39	3.30	0.99	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	185.24	0.87	0.25	0.75
breast, adult, donor1	10080-102A8	18.31	1.26	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	91.98	2.67	1.02	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	83.18	1.24	2.16	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	141.12	3.68	1.84	1.38
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	53.02	0.97	0.97	0.24
carcinoid cell line:NCI-H1770	10703-109H1	84.63	1.41	0.47	0.94
carcinoid cell line:NCI-H727	10735-110B6	66.72	1.09	0.77	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	71.94	1.58	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	88.10	1.86	1.06	0.53
caudate nucleus - adult, donor10196	10177-103C6	70.23	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	71.45	1.67	0.67	0.67
caudate nucleus, adult, donor10258	10379-105H1	35.91	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	65.92	3.66	0.73	0.73
cerebellum - adult, donor10196	10173-103C2	113.62	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	151.17	4.06	0.43	1.07
cerebellum, adult, pool1	10083-102B2	32.08	0.69	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	140.32	5.81	0.00	0.00
cerebral meninges, adult	10188-103D8	31.77	0.00	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	36.54	4.39	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	60.39	0.43	0.14	0.43
cervical cancer cell line:ME-180	10553-107I4	92.14	0.99	0.66	0.66
cervix, adult, pool1	10013-101C4	85.67	1.36	0.73	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	31.63	0.42	0.42	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	18.29	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	170.01	1.74	1.99	0.87
choriocarcinoma cell line:SCH	10785-110H2	82.06	1.48	1.23	1.23
choriocarcinoma cell line:T3M-3	10618-108G6	90.13	0.47	0.95	0.95
chorionic membrane cells, donor1	12238-129G6	39.60	0.57	0.85	0.57
chorionic membrane cells, donor2	12239-129G7	56.87	0.70	0.70	0.10
chorionic membrane cells, donor3	12240-129G8	64.84	2.75	3.30	2.20
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	69.68	1.01	4.04	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	56.67	0.38	1.15	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	79.19	0.42	1.06	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	102.46	0.77	1.03	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	112.96	4.11	0.73	1.69
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	127.26	2.44	0.41	1.43
chronic myelogenous leukemia cell line:K562	10454-106G4	96.29	0.59	1.18	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	285.12	0.78	1.82	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	62.63	1.37	0.69	1.37
clear cell carcinoma cell line:TEN	10636-108I6	85.19	1.21	0.52	0.52
colon carcinoma cell line:CACO-2	10513-107D9	127.95	1.28	0.55	0.37
colon carcinoma cell line:COLO-320	10420-106C6	150.89	1.52	0.38	0.38
colon, adult, donor1	10082-102B1	38.08	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	72.85	1.41	0.35	0.12
colon, fetal, donor1	10070-101I7	42.02	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	45.84	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	112.18	0.85	0.85	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	96.29	0.75	0.30	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	107.59	0.71	0.28	0.42
corpus callosum, adult, pool1	10042-101F6	124.94	0.77	1.00	0.44
cruciate ligament, donor2	10295-104G7	57.54	3.24	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	32.91	2.41	1.61	0.00
diencephalon, adult	10193-103E4	36.96	0.00	0.24	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	108.38	2.30	1.84	1.15
ductal cell carcinoma cell line:KLM-1	10438-106E6	159.51	0.77	1.54	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	71.49	0.48	0.24	0.48
ductus deferens, adult	10196-103E7	56.81	0.00	1.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	40.33	4.32	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	66.21	2.94	1.47	0.74
dura mater, adult, donor1	10041-101F5	136.10	0.74	0.66	0.58
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	64.18	1.55	0.22	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	86.41	0.14	0.29	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	46.86	1.23	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	57.82	0.61	2.42	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	46.62	1.23	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	59.11	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	113.30	2.01	0.67	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	97.14	1.63	1.27	1.45
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	57.89	0.32	1.13	0.32
epidermoid carcinoma cell line:A431	10426-106D3	173.85	1.56	0.89	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	188.63	1.65	2.09	0.88
epididymis, adult	10197-103E8	60.70	2.72	0.00	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	27.85	0.89	0.00	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	53.09	0.00	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	88.59	1.83	1.57	0.52
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	86.22	1.08	0.49	1.28
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	75.28	1.57	0.78	0.67
esophagus, adult, pool1	10015-101C6	55.64	1.38	0.32	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	121.85	0.75	0.88	0.13
eye - muscle inferior rectus, donor1	10272-104E2	36.22	7.24	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	21.04	8.42	0.00	0.00
eye - muscle medial, donor2	10299-104H2	14.88	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	30.96	4.59	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	30.61	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	45.25	1.02	0.76	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	90.91	1.41	0.77	1.15
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	48.43	0.71	0.47	0.71
frontal lobe, adult, pool1	10040-101F4	66.52	0.47	0.66	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	123.70	3.00	0.60	1.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	95.00	0.64	0.27	0.37
gall bladder, adult	10198-103E9	54.81	0.48	1.45	0.24
gamma delta positive T cells, donor1	11937-126A2	83.75	0.54	3.22	0.00
gamma delta positive T cells, donor2	11938-126A3	91.13	0.00	2.24	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	68.65	1.06	0.63	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	85.10	0.97	1.74	0.39
gastric cancer cell line:AZ521	10549-107H9	85.75	0.98	0.98	0.66
gastric cancer cell line:GSS	10560-108A2	37.52	1.83	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	73.11	1.83	0.69	0.46
giant cell carcinoma cell line:LU65	10487-107B1	79.29	1.38	1.26	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	74.88	0.42	0.56	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	77.57	1.75	1.25	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	42.85	0.95	0.42	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	34.41	0.00	0.28	0.14
glioblastoma cell line:T98G	10485-107A8	49.34	0.66	0.22	0.11
glioma cell line:GI-1	10413-106B8	88.74	0.29	0.29	0.29
globus pallidus - adult, donor10196	10175-103C4	46.65	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	118.63	2.93	0.49	0.73
globus pallidus, adult, donor10258	10367-105F7	58.88	2.74	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	42.63	1.07	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	70.97	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	98.36	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	36.59	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	33.92	0.32	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	97.79	2.75	0.46	1.38
hIPS +CCl2, biol_rep2	14384-156C1	108.83	2.29	1.37	1.37
hIPS +CCl2, biol_rep3	14385-156C2	72.78	2.58	2.58	0.64
hIPS, biol_rep1	14380-156B6	51.74	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	58.30	2.06	1.37	1.37
hIPS, biol_rep3	14382-156B8	50.76	1.10	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	75.86	1.72	1.15	0.29
heart - mitral valve, adult	10205-103F7	52.62	1.49	0.60	0.30
heart - pulmonic valve, adult	10206-103F8	67.72	2.61	0.78	0.52
heart - tricuspid valve, adult	10207-103F9	57.45	5.83	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	64.48	1.22	0.41	0.82
heart, adult, diseased, donor1	10051-101G6	59.62	1.70	2.13	0.85
heart, adult, pool1	10016-101C7	43.47	0.46	0.23	0.00
heart, fetal, pool1	10046-101G1	104.63	0.62	0.82	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	44.43	1.23	0.62	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	40.43	3.57	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	114.81	1.55	0.66	0.66
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	114.21	2.18	0.97	0.85
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	140.57	1.92	0.61	0.91
hepatoma cell line:Li-7	10484-107A7	48.49	0.33	0.00	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	138.59	1.11	2.01	0.80
hippocampus - adult, donor10196	10169-103B7	55.83	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	88.17	3.88	0.61	0.82
hippocampus, adult, donor10258	10374-105G5	40.83	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	33.84	0.35	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	135.50	0.61	4.27	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	60.28	1.37	1.57	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	90.64	0.51	0.25	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	71.05	1.13	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	76.95	5.68	8.52	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	71.37	2.66	3.04	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	87.00	1.17	0.58	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	83.37	2.37	1.94	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	82.58	0.83	0.42	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	57.78	0.24	0.95	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	78.91	2.09	0.96	0.96
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	52.52	1.35	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	76.68	1.88	1.88	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	75.66	0.98	4.42	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	132.66	1.75	2.62	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	84.76	2.48	1.91	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	68.03	1.74	0.87	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	108.45	1.50	1.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	86.28	2.45	1.88	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	91.85	1.36	0.91	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	70.16	2.19	1.57	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	61.40	1.14	1.14	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	61.55	3.19	1.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	58.89	3.89	1.20	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	75.38	1.29	1.11	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	70.47	0.29	0.86	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	133.11	1.63	2.04	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	77.81	1.76	4.22	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	53.21	0.95	1.58	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	65.06	1.82	1.51	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	68.26	0.52	1.55	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	60.44	3.32	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	68.75	0.26	0.26	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	58.29	1.53	2.05	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	61.34	3.03	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	61.16	1.34	0.67	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	76.56	1.45	1.21	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	92.25	2.23	1.34	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	94.15	0.49	3.90	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	77.02	2.44	1.83	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	702.70	9.76	6.51	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	138.66	1.32	1.32	1.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	94.14	2.19	1.64	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	84.32	1.81	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	71.53	1.78	1.07	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	69.22	2.39	3.58	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	101.57	1.63	1.08	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	51.99	1.35	0.81	0.27
immature langerhans cells, donor1	11904-125F5	166.35	1.45	0.97	0.24
immature langerhans cells, donor2	11905-125F6	128.33	0.00	0.79	0.79
insula, adult, pool1	10039-101F3	75.14	0.47	0.66	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	39.67	0.65	0.33	1.30
kidney, adult, pool1	10017-101C8	65.78	1.50	0.40	0.20
kidney, fetal, pool1	10045-101F9	82.55	0.50	0.42	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	109.21	0.99	0.57	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	35.53	0.55	0.55	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	74.68	1.28	0.18	0.73
left atrium, adult, donor1	10079-102A7	26.70	0.54	0.00	0.00
left ventricle, adult, donor1	10078-102A6	21.74	1.01	0.51	0.51
leiomyoblastoma cell line:G-402	10721-110A1	45.97	0.55	0.00	0.27
leiomyoma cell line:10964C	10569-108B2	57.12	1.44	1.44	1.44
leiomyoma cell line:15242A	10570-108B3	49.46	0.54	2.17	0.54
leiomyoma cell line:15425	10571-108B4	66.77	1.94	1.70	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	11.50	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	166.46	2.36	0.59	0.35
liposarcoma cell line:KMLS-1	10782-110G8	53.74	1.25	0.16	0.16
liposarcoma cell line:SW 872	10726-110A6	61.41	0.49	0.85	0.61
liver, adult, pool1	10018-101C9	41.97	1.78	0.16	0.16
liver, fetal, pool1	10086-102B5	28.22	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	47.39	0.73	0.29	0.73
locus coeruleus, adult, donor10252	10165-103B3	67.91	1.66	0.92	0.55
locus coeruleus, adult, donor10258	10375-105G6	30.19	0.28	0.28	0.28
locus coeruleus, newborn, donor10223	10362-105F2	102.63	2.52	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	61.17	0.55	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	22.75	0.69	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	59.98	0.79	0.66	0.66
lung, adult, pool1	10019-101D1	71.82	0.83	0.35	0.12
lung, fetal, donor1	10068-101I5	201.78	2.57	0.57	0.00
lung, right lower lobe, adult, donor1	10075-102A3	33.91	4.12	0.00	0.00
lymph node, adult, donor1	10077-102A5	44.97	0.95	1.89	0.47
lymphangiectasia cell line:DS-1	10727-110A7	74.74	1.10	0.66	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	106.40	1.06	0.00	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	228.51	2.55	1.70	0.85
mature adipocyte, donor1	12231-129F8	47.51	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	55.20	0.62	0.00	0.00
mature adipocyte, donor3	12233-129G1	59.27	0.24	0.00	0.24
mature adipocyte, donor4	12234-129G2	65.54	0.26	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	107.45	0.48	0.24	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	57.53	2.26	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	65.10	3.68	0.18	1.10
medial frontal gyrus, adult, donor10258	10368-105F8	31.45	0.32	0.64	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	93.83	1.28	0.43	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	64.29	2.87	3.54	3.38
medial temporal gyrus, adult, donor10252	10156-103A3	85.53	3.40	0.85	1.27
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	34.67	1.93	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	330.13	28.71	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	45.23	2.15	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	59.06	2.60	0.00	1.30
medulla oblongata, adult, donor10252	10155-103A2	86.54	2.79	0.31	0.77
medulla oblongata, adult, pool1	10038-101F2	86.36	0.41	0.65	0.24
medulla oblongata, newborn, donor10223	10361-105F1	52.08	1.04	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	222.08	5.09	0.89	2.21
medulloblastoma cell line:ONS-76	10759-110E3	43.53	0.37	0.12	0.24
melanoma cell line:COLO 679	10514-107E1	63.97	1.15	0.00	0.43
melanoma cell line:G-361	10465-106H6	99.63	2.99	0.27	0.54
meningioma cell line:HKBMM	10691-109F7	42.87	0.18	0.54	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	119.84	4.41	1.76	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	76.47	0.78	1.30	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	79.17	0.77	1.23	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	61.81	0.36	1.27	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	62.12	1.24	0.83	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	47.48	0.42	0.42	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	43.14	0.77	0.58	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	51.36	1.39	0.69	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	53.38	0.51	0.17	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	55.67	0.92	0.69	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	63.40	0.93	0.40	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	58.74	0.41	0.68	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	79.10	0.57	0.85	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	47.10	0.66	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	54.10	0.14	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	72.26	1.05	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	51.65	0.61	1.22	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	43.49	0.36	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	36.83	0.41	0.83	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	46.05	1.14	0.68	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	78.04	1.68	0.84	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	36.91	0.15	1.05	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	50.59	0.61	0.61	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	48.60	0.74	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	53.23	0.29	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	53.05	1.68	1.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	40.64	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	51.92	1.02	1.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	48.69	0.52	0.52	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	52.07	0.62	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	52.95	1.18	1.41	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	54.49	0.68	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	49.12	1.57	0.79	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	63.48	1.39	1.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	72.39	0.58	0.58	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	55.78	0.89	0.22	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	66.58	1.68	0.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	60.87	0.73	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	54.38	0.00	1.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	51.58	1.23	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	55.84	0.00	1.72	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	30.08	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	55.86	0.00	0.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	39.28	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	44.78	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	34.35	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	40.43	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	35.68	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	34.77	1.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	4.77	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	42.69	0.00	1.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	46.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	39.90	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	36.21	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	34.39	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	30.99	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	23.63	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	23.83	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	18.28	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	21.51	0.31	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	20.05	0.00	1.34	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	17.74	0.00	3.55	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	20.54	2.57	7.70	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	31.67	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	21.77	0.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	15.70	1.12	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	26.71	0.00	1.91	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	24.18	0.00	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	23.99	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	16.47	0.00	3.80	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	24.28	0.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	20.59	0.82	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	22.62	0.40	0.60	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	24.99	0.00	0.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	14.26	1.02	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	24.76	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	77.49	0.94	0.94	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	24.09	0.23	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	55.56	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	44.59	1.03	2.26	0.92
mesothelioma cell line:Mero-25	10850-111F4	62.87	2.04	0.68	0.00
mesothelioma cell line:Mero-41	10851-111F5	56.47	2.20	0.73	0.73
mesothelioma cell line:Mero-48a	10852-111F6	54.47	0.89	0.89	0.44
mesothelioma cell line:Mero-82	10853-111F7	64.12	1.84	1.31	1.05
mesothelioma cell line:Mero-83	10854-111F8	61.62	1.19	1.53	0.17
mesothelioma cell line:Mero-84	10855-111F9	83.16	1.52	0.51	0.76
mesothelioma cell line:Mero-95	10856-111G1	53.21	0.62	0.21	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	68.74	1.33	0.83	0.17
mesothelioma cell line:NCI-H226	10846-111E9	62.62	0.90	1.09	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	50.56	0.17	1.20	0.68
mesothelioma cell line:NCI-H28	10845-111E8	44.53	0.76	0.51	0.25
mesothelioma cell line:No36	10857-111G2	37.84	0.65	0.98	0.33
mesothelioma cell line:ONE58	10858-111G3	77.76	2.17	1.08	0.27
migratory langerhans cells, donor1	11901-125F2	199.98	0.77	0.58	0.19
migratory langerhans cells, donor2	11902-125F3	116.13	1.47	0.24	0.12
migratory langerhans cells, donor3	11903-125F4	116.84	0.90	0.36	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	33.63	1.63	1.96	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	75.45	1.70	1.48	1.70
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	62.20	1.38	0.23	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	70.03	1.71	0.57	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	128.80	0.74	0.18	0.18
myeloma cell line:PCM6	10474-106I6	124.53	1.58	1.78	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	40.08	1.01	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	40.60	0.20	0.39	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	44.12	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	56.63	0.29	0.22	0.15
nasal epithelial cells, donor2	12227-129F4	59.06	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	100.77	1.38	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	59.87	0.75	0.37	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	49.35	1.48	0.21	0.42
neuroblastoma cell line:NH-12	10555-107I6	111.25	1.68	1.86	0.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	65.95	2.61	0.24	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	58.44	1.11	0.48	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	70.24	1.61	0.60	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	59.76	0.64	0.00	1.91
neurofibroma cell line:Hs 53.T	10729-110A9	40.72	0.27	0.27	0.00
neutrophil PMN, donor1	12133-128D9	59.50	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	159.37	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	142.06	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	209.71	2.03	1.18	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	29.62	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	42.00	0.32	0.96	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	55.18	0.26	0.79	0.26
nucleus accumbens, adult, pool1	10037-101F1	78.27	0.84	0.47	0.19
occipital cortex - adult, donor10196	10172-103C1	55.63	4.12	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	94.46	3.22	0.00	0.27
occipital cortex, newborn, donor10223	10355-105E4	49.86	0.00	0.73	0.00
occipital lobe, adult, donor1	10076-102A4	40.67	0.00	1.57	0.00
occipital lobe, fetal, donor1	10073-102A1	47.63	0.86	0.86	1.29
occipital pole, adult, pool1	10036-101E9	51.56	0.55	0.32	0.16
olfactory region, adult	10195-103E6	40.31	0.57	0.38	0.38
optic nerve, donor1	10277-104E7	42.02	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	82.47	0.80	0.68	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	98.78	0.14	0.27	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	76.03	1.52	1.35	0.85
oral squamous cell carcinoma cell line:SAS	10544-107H4	95.76	1.50	1.96	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	47.33	0.88	0.29	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	78.48	2.80	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	88.85	0.64	0.00	0.21
ovary, adult, pool1	10020-101D2	79.49	1.14	0.61	0.61
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	79.01	4.58	1.83	1.10
pancreas, adult, donor1	10049-101G4	31.04	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	74.64	1.40	0.28	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	69.50	2.21	1.19	1.02
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	102.83	0.66	1.32	0.33
paracentral gyrus, adult, pool1	10035-101E8	60.50	0.18	0.73	0.18
parietal cortex, adult, donor10258	10373-105G4	52.11	2.20	0.73	0.73
parietal lobe - adult, donor10196	10171-103B9	53.61	0.94	0.94	0.94
parietal lobe, adult, donor10252	10157-103A4	81.52	2.00	1.43	0.29
parietal lobe, adult, pool1	10034-101E7	58.42	0.53	0.53	0.00
parietal lobe, fetal, donor1	10072-101I9	77.59	0.97	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	62.81	0.37	0.00	0.75
parotid gland, adult	10199-103F1	80.78	1.23	0.00	0.00
penis, adult	10200-103F2	47.80	1.61	1.07	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	74.56	1.86	1.49	0.93
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	88.58	1.60	0.73	0.73
pineal gland - adult, donor10196	10179-103C8	53.54	2.58	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	119.63	1.78	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	45.15	1.88	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	131.53	3.04	1.01	2.02
pituitary gland, adult, donor10252	10162-103A9	196.48	3.65	0.00	0.52
pituitary gland, adult, donor10258	10378-105G9	70.65	2.55	0.00	0.00
placenta, adult, pool1	10021-101D3	66.87	0.75	0.43	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	146.07	2.38	0.66	0.93
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	37.66	0.16	0.31	0.16
pons, adult, pool1	10033-101E6	60.59	0.52	0.17	0.34
postcentral gyrus, adult, pool1	10032-101E5	60.67	0.44	0.09	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	18.82	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	87.69	1.31	1.60	0.58
prostate cancer cell line:PC-3	10439-106E7	89.12	2.18	1.45	1.09
prostate, adult, pool1	10022-101D4	49.97	0.91	0.36	0.09
putamen, adult, donor10196	10176-103C5	76.01	3.54	0.24	0.94
putamen, adult, donor10252	10152-102I8	45.10	0.00	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	62.29	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	38.17	0.48	0.72	0.48
putamen, newborn, donor10223	10365-105F5	134.19	1.50	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	66.92	0.58	0.29	1.16
rectum, fetal, donor1	10067-101I4	45.90	2.78	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	51.94	0.64	1.06	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	42.25	1.24	0.83	0.41
retina, adult, pool1	10030-101E3	90.06	0.70	1.29	0.40
retinoblastoma cell line:Y79	10475-106I7	102.36	0.52	0.52	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	57.29	0.49	0.61	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	165.63	3.66	0.84	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	29.56	0.76	0.76	0.00
salivary acinar cells, donor1	11771-123I7	84.65	0.32	0.65	0.32
salivary acinar cells, donor2	11772-123I8	80.96	1.24	0.28	1.38
salivary acinar cells, donor3	11773-123I9	38.40	1.99	0.00	0.66
salivary gland, adult, pool1	10093-102C3	93.80	0.00	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	119.81	1.43	0.42	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	95.45	1.41	0.94	0.35
seminal vesicle, adult	10201-103F3	59.79	2.65	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	87.70	0.97	0.73	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	47.06	1.01	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	65.23	4.01	1.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	81.00	0.81	1.75	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	93.51	0.44	0.44	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	86.96	0.90	0.39	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	51.78	4.97	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	81.44	0.72	0.60	0.60
skeletal muscle, fetal, donor1	10066-101I3	48.24	1.01	0.00	1.01
skin, adult, donor1	10074-102A2	13.57	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	62.49	0.63	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	43.02	0.67	1.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	88.57	5.04	1.26	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	88.86	0.58	0.58	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	90.33	0.49	0.82	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	167.12	3.86	0.64	1.61
small cell lung carcinoma cell line:WA-hT	10562-108A4	84.12	0.87	1.53	0.65
small intestine, adult, pool1	10024-101D6	96.51	1.67	0.72	0.24
small intestine, fetal, donor1	10064-101I1	54.30	1.72	0.98	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	46.16	0.51	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	50.66	0.78	0.52	0.52
somatostatinoma cell line:QGP-1	10781-110G7	26.80	0.80	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	50.24	2.98	0.46	0.69
spinal cord, adult, donor10252	10159-103A6	92.65	1.97	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	62.95	3.46	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	59.76	0.00	1.22	1.22
spinal cord, newborn, donor10223	10359-105E8	95.06	1.38	0.46	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	61.24	0.75	0.45	0.60
spleen, adult, pool1	10025-101D7	75.77	0.99	0.66	0.33
spleen, fetal, pool1	10044-101F8	87.48	0.40	0.48	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	156.51	1.24	1.24	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	82.60	1.33	0.38	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	128.25	2.10	1.75	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	91.48	0.78	0.39	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	228.94	2.81	1.69	1.58
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	47.44	0.42	1.69	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	60.50	0.42	0.42	0.00
stomach, fetal, donor1	10062-101H8	64.08	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	56.97	0.57	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	271.37	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	81.42	2.70	0.42	0.21
substantia nigra, adult, donor10258	10371-105G2	49.14	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	49.46	0.00	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	97.44	1.38	2.52	0.46
temporal lobe, adult, pool1	10031-101E4	57.64	0.59	0.51	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	69.09	0.71	2.14	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	86.59	2.20	0.44	0.44
tenocyte, donor1	11763-123H8	61.79	3.14	2.79	0.70
tenocyte, donor2	11765-123I1	26.32	0.00	0.38	0.38
tenocyte, donor3	11768-123I4	54.49	2.97	4.08	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	112.68	3.74	1.53	0.68
teratocarcinoma cell line:NCR-G1	10798-110I6	119.77	2.16	1.85	0.31
teratocarcinoma cell line:PA-1	10807-111A6	86.94	1.39	0.93	0.93
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	76.17	1.27	0.38	1.02
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	146.35	1.13	1.51	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	129.35	2.29	1.20	0.65
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	222.78	7.17	5.86	2.93
testis, adult, pool1	10026-101D8	128.85	6.44	2.47	1.07
testis, adult, pool2	10096-102C6	239.53	12.63	6.77	3.61
thalamus - adult, donor10196	10168-103B6	59.62	1.10	1.10	0.00
thalamus, adult, donor10252	10154-103A1	102.05	2.19	0.47	0.94
thalamus, adult, donor10258, tech_rep1	10370-105G1	33.87	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	22.07	0.99	0.16	0.16
thalamus, newborn, donor10223	10366-105F6	47.75	0.58	0.00	0.58
throat, adult	10209-103G2	62.42	1.50	0.25	0.50
throat, fetal, donor1	10061-101H7	42.66	0.91	1.22	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	112.68	1.39	0.00	1.39
thymus, adult, pool1	10027-101D9	130.03	2.49	1.49	0.80
thymus, fetal, pool1	10043-101F7	160.22	1.45	0.52	0.94
thyroid carcinoma cell line:KHM-5M	10776-110G2	95.07	1.60	0.80	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	62.16	0.42	1.40	0.42
thyroid, adult, pool1	10028-101E1	68.40	0.84	0.47	0.19
thyroid, fetal, donor1	10060-101H6	40.60	1.85	0.79	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	64.67	12.32	0.00	0.00
tongue, adult	10203-103F5	63.26	0.93	0.47	0.00
tongue, fetal, donor1	10059-101H5	35.47	0.79	1.18	0.39
tonsil, adult, pool1	10047-101G2	122.92	0.90	0.90	0.30
trachea, adult, pool1	10029-101E2	65.44	0.65	0.33	0.16
trachea, fetal, donor1	10058-101H4	40.39	1.15	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	64.12	2.13	0.35	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	130.50	0.61	0.41	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	100.28	0.63	1.10	0.94
tridermal teratoma cell line:HGRT	10694-109G1	30.44	3.81	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	49.10	0.59	0.93	0.08
umbilical cord, fetal, donor1	10057-101H3	31.30	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	88.73	0.85	0.17	0.17
uterus, fetal, donor1	10055-101H1	47.10	0.00	0.00	0.00
vagina, adult	10204-103F6	32.96	0.00	0.00	0.00
vein, adult	10191-103E2	64.01	1.10	0.00	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	68.90	0.53	0.80	0.27